Charlena buys ABBV 54.11: Bristol-Myers Squibb, AbbVieâs multiple myeloma therapy gets âbreakthroughâ status
Bristol-Myers Squibb (NYSE:BMY) and local sector player AbbVie Inc (NYSE:ABBV) said today that the US FDA had granted Breakthrough Therapy status to elotuzumab, a humanized IgG1 monoclonal antibody co-developed by the two companies, for use together with . ... ...
45 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home